We now have data from an eighth randomized clinical trial of hypofractionated radiation therapy. There are no surprises: … READ MORE …
Filed under: Diagnosis, Management, Risk, Treatment | Tagged: hypofractionation, outcomes, radiation | Leave a comment »
“Don’t underestimate patients” is a new blog post on The Health Care Blog web site by George Berger, who is a regular commentator on the posts on this web site. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Treatment | Tagged: "patient power", decision, making, risk, shared | 2 Comments »
A new report in the Journal of Clinical Oncology suggests that younger patients had a somewhat lower risk for biopsy-based Gleason score upgrade while on active surveillance (AS) than older patients. … READ MORE …
Filed under: Diagnosis, Management, Treatment | Tagged: risk, active, surveillance, progression, age | 6 Comments »
According to an article from Kaiser Health News on the CNN web site today, “People with advanced cancer don’t know enough about their disease to make informed decisions about treatment or how they want to spend their remaining time.” … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: death, expectations, illness, realities, terminal | 16 Comments »
In general, being of African American race is not a good thing when it comes to prostate cancer-related risk (for getting diagnosed with the disease or for outcomes over time). However, … … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: African American, Provenge, sipuleucel-T, Treatment | Leave a comment »
An abstract that we missed at the ASCO meeting this year came to our attention when we read this article by Dr. Jeffrey Kirshner: “Ten practice changes I will make after attending ASCO 2017“. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Treatment | Tagged: efficacy, Larotrectinib, LOXO-101, safety | 5 Comments »
